Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric …

M de Fátima dos Santos Sampaio… - Basic & Clinical …, 2024 - Wiley Online Library
Studies have demonstrated the neuroprotective effect of cannabidiol (CBD) and other
Cannabis sativa L. derivatives on diseases of the central nervous system caused by their …

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke

I Raïch, J Lillo, R Rivas-Santisteban… - International Journal of …, 2024 - mdpi.com
áStroke is one of the leading causes of death. It not only affects adult people but also many
children. It is estimated that, every year, 15 million people suffer a stroke worldwide. Among …

Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain

MT Chevalier, M Al-Waeel, AM Alsharabasy… - Molecular …, 2024 - ACS Publications
Cannabidiol (CBD) is the most relevant nonpsychostimulant phytocompound found in
Cannabis sativa. CBD has been extensively studied and has been proposed as a …

[HTML][HTML] Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey

L Brunetti, F Francavilla, M Leopoldo, E Lacivita - Pharmaceuticals, 2024 - mdpi.com
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter regulating numerous
physiological functions, and its dysregulation is a crucial component of the pathological …

A literature review on the therapeutic applicability of cannabidiol in epilepsy, multiple sclerosis and Parkinson's disease

MF dos Santos Sampaio, YB de Paiva… - Authorea …, 2023 - essopenarchive.org
Neurodegenerative diseases have complex etiologies, however, neuroinflammation and
oxidative stress are important markers in this pathogenesis and, in this sense, cannabinoids …